Premium
IC‐P‐068: Family History Modulates TOMM40's Effect on Alzheimer's Disease Vascular Risk Factors and Neurodegeneration
Author(s) -
Webb Joseph L.,
Lutz Michael W.,
Wennberg Alexandra M.V.,
Roses Allen D.,
Johnson Sterling C.,
Bendlin Barbara B.,
Willette Auriel A.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.098
Subject(s) - medicine , apolipoprotein e , neurodegeneration , risk factor , genotype , linkage disequilibrium , homocysteine , endocrinology , alzheimer's disease , disease , biology , genetics , haplotype , gene
EFFECT ON ALZHEIMER’S DISEASE VASCULAR RISK FACTORS AND NEURODEGENERATION Joseph L. Webb, Michael W. Lutz, Alexandra M. V. Wennberg, Allen D. Roses, Sterling C. Johnson, Barbara B. Bendlin, Auriel A. Willette, Iowa State University, Ames, IA, USA; Duke University Bryan ADRC, Durham, NC, USA; 3 Mayo Clinic, Rochester, MN, USA; Duke University, Durham, NC, USA; Zinfandel Pharmaceuticals, Inc., Chapel Hill, NC, USA; Cabernet Pharmaceuticals, Chapel Hill, NC, USA; 7 Geriatric Research Education and Clinical Center, Wm. S. Middleton Veterans Hospital, Madison, WI, USA; 8 Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; 10 Wisconsin Alzheimer’s Institute, Madison, WI, USA; 11 Waisman Laboratory for Brain Imaging and Behavior, University of Wisconsin-Madison, Madison, WI, USA; National Institute on Aging/National Institutes of Health (NIA/NIH), Baltimore, MD, USA. Contact e-mail: jlwebb@iastate.edu